New Innovative Laser Technology for Stretch Mark Treatment

New Innovative Laser Technology for Stretch Mark Treatment

Promising results on stretch mark treatment announced at the 38th National Congress of Aesthetic Medicine and Dermatological Surgery in Paris, France

Professor Jean-Paul Meningaud (1) presented his research into the possibilities of RecoSMA® (LINLINE) in stretch mark treatment. This unique & revolutionary new method to repair damaged human tissue has been developed and patented by LINLINE, and is implemented in the MULTILINE™ series of devices. The 38th National Congress of Aesthetic Medicine and Dermatological Surgery, was held 8th and 9th September 2017 at the Palais des Congrès, Paris, by the French Society of Aesthetic Medicine. www.sfme.info

The French Society of Aesthetic Medicine was founded in 1973, and celebrates its 44th anniversary this year. It brings together physicians, experts and non-experts who, in their daily practice, offer their patients advice, care or treatments to improve their aesthetic appearance. The French Society of Aesthetic Medicine organises every year it’s National Congress which attracts more than 1,000 participants. It publishes the "Journal of Aesthetic Medicine and Dermatological Surgery" every three months.

The objective of this study was to assess the efficacy of RecoSMA® technology for Striae Distensae (SD). The study investigated the stimulation of fibroblasts and the improvement of the quality of the skin in the area affected by SD and to study the response of the organism to these micro traumas in cell regeneration leading to newly formed collagen and elastin fibres. The prospective research project was conducted by the Department of Plastic, Reconstructive and Aesthetic Surgery at the Henri Mondor Hospital, Paris.

Method: A total of 20 patients with various stages of SD were included. Pregnant or breast feeding patients and patients who had previous treatment for SD were excluded. Treatment was undertaken using an Er:YAG laser 2936nm with RecoSMA ® technology (LINLINE). Each patient received a total of 6 sessions with four week intervals. During treatment no anaesthetic was required or needed. Follow ups were 3 and 6 months.

Results: The results were analysed by examining the photographs and ultrasound images of the areas treated.

• 10% Patients experienced very good improvement

• 60% Patients showed good improvement

• 20% moderate improvement

• 10% slight improvement

Conclusion: After 3 months the study revealed 70% of patients had a good or very good improvement of SD.

• The RecoSMA® laser vastly improves the elasticity and firmness of the skin

• Improves significantly scar quality

• Is effective in treating SD with no side effects

• Has very promising preliminary results

RecoSMA ® is a unique technology, recently invented by LINLINE, to treat different tissue conditions such as aged skin, scarring, age-related hyperpigmentation, non-healing wounds, psoriasis etc. It is based on a sophisticated laser optical system, converting the main laser beam into 10,000 microbeams per square cm, which simultaneously interact with the tissue. The powerful mechanical waves from every micro beam scatter from the surface to the deeper layers, creating what has never existed before; non-thermal partial damage of human cells up to 6 mm in depth. This new technology is incomparable to any other - including light or ultrasound based methods. This is due to the great response of the tissue treated, leading to its total regeneration, its functional restoration, and the promotion of fast neovascularisation, becoming truly younger and healthier. The evidence of the effectiveness of the new RecoSMA® technology is backed up by numerous pre-clinical and clinical studies for aged skin rejuvenation and lifting, correction of scars, treating trophic ulcers and many other applications.

(1) Professor Jean-Paul Meningaud, MD, PhD, FEBOMS, Maxillofacial Surgeon, Head of the Department of Plastic, Reconstructive and Aesthetic Surgery at the Henri Mondor Hospital, Paris. A Fellow of the European Board of Oro-Maxillofacial Surgery, he graduated in microsurgery and holds the HDR (postdoctoral degree authorising the holder to direct the research of others). He received the James Barret Brown award in 2011. In 2014 he was elected to be President of the EACMFS (European Association for Cranio Maxillo Facial Surgery) for 2018-2020. He is in charge of diplomas in cosmetic medicine and runs research into regenerative medicine and aesthetic surgery.

to news list